Vyaire Medical Inc. is a global company focused exclusively on supporting breathing through every stage of life. The company’s portfolio is trusted and preferred by the respiratory community and designed to enable, enhance and extend lives. https://www.vyaire.com/
Consultant Neonatologist with Research Interest, Department of Neonatology, at Cambridge University Hospitals NHS Trust (U.K)
Tertiary level Neonatal Intensive Care: 20 years of experience, 11 years as Consultant
Neonatal Transport: 14 years of Experience, 11 years as a consultant
Neonatal Echocardiography: 13 years of experience
RESEARCH INTEREST
Github's Profile : https://github.com/belteki
Research Gate's profile : https://www.researchgate.net/profile/Gusztav-Belteki
Chief of Neonatology Department, “V.Buzzi”-Childrens’ Hospital ASST-FBF-Sacco,Milan-Italy, since 2004 until now
Active member of: Italian Society of Neonatology (SIN), European Scientific Collaboration on Neonatal Resuscitation (ESCNR) , European Society of Pediatric Research (ESPR) and Union of European Neonatal and Perinatal Societies (UENPS)
Chairman of the ESCNR 2018-2020 years
President of the Lombardy section of the Italian Neonatal Society (SIN) 2018-2021 years
Temporary Lecturer by the University of Milan (Master in Neonatology and Upgrade Course in Mechanical Ventilation), academic course, since 2002 to present.
Adjunct Professor at the Pediatrics School of the University of Milan since academic course 2014/2015
100 scientific papers published on Pub-Med web site.Co-Author of : a chapter on the book “Genetics of epilepsy and genetic epilepsies”, edited by Fondazione Mariani in 2010; a chapter on mechanical ventilation and on N-CPAP on Neonatology Textbook 2017 edition; a chapter on lung volume optimization on Manual of Neonatal Respiratory Care (2017); a chapter entitled “Prenatal attachment in twin pregnancy” on the book “Multiple Pregnancy : new challenges “edited by Julio Elito Jr, 2019).Coauthorof the chapter “Sustained lung inflation” on the book “ Essentials of Neonatal Ventilation” , Elsevier Edition, 1st edition, 2019.
Dr. Cataldo is a physician anesthesiologist with CareMount Medical serving Westchester and Putnam Counties in NY. With extensive clinical experience in anesthetic delivery and critical care, he aims to improve patient care and safety through medical device design and implementation. Steven believes that successful innovation in medical care revolves around offering new techniques and procedures available to clinicians through device design. Rather than modifying current market devices to add new features or decrease failures, effective change within the field relies on the evolution of healthcare moving forward, using science and technology to create novel ways to support patients’ physiologic needs.
Through the design and implementation of the SuperNO2VA™ platform, Steven has pioneered a new modality of airway management and respiratory care through controlled nasal ventilation. This makes use of the body’s most natural route of ventilation and allows for improved care in patients receiving anesthetic medications without advanced airway management, paralleling the current trends in minimally invasive medical care and maximizing clinician workflow. To train this new clinical care delivery system and its associated novel market within sedation anesthesia, Steven enjoys being in the field, traveling and teaching clinicians in person within the operating room, lecture hall, and at international meetings.
Dr. Cataldo earned his M.D. and completed his residency training in Anesthesia at SUNY Downstate Medical Center in Brooklyn, NY. He is an active member of the American Society of Anesthesiologists, New York State Society of Anesthesiologists, Society for Airway Management, and Society for Head and Neck Anesthesia.
Prof Ross Freebairn is well known as an expert in the field of intensive care and has published many studies on important topics of lung protection strategies.
His lecture will explain how the use of PEEP is one of the most important parts of the ventilation treatment package and probably the least understood as well. Professor Freebairn will explain the reasons why PEEP should be considered and how it should be set based on the patients clinical status and lung condition.
Consultant Neonatologist with Research Interest, Department of Neonatology, at Cambridge University Hospitals NHS Trust (U.K)
Tertiary level Neonatal Intensive Care: 20 years of experience, 11 years as Consultant
Neonatal Transport: 14 years of Experience, 11 years as a consultant
Neonatal Echocardiography: 13 years of experience
RESEARCH INTEREST
Github's Profile : https://github.com/belteki
Research Gate's profile : https://www.researchgate.net/profile/Gusztav-Belteki
Chief of Neonatology Department, “V.Buzzi”-Childrens’ Hospital ASST-FBF-Sacco,Milan-Italy, since 2004 until now
Active member of: Italian Society of Neonatology (SIN), European Scientific Collaboration on Neonatal Resuscitation (ESCNR) , European Society of Pediatric Research (ESPR) and Union of European Neonatal and Perinatal Societies (UENPS)
Chairman of the ESCNR 2018-2020 years
President of the Lombardy section of the Italian Neonatal Society (SIN) 2018-2021 years
Temporary Lecturer by the University of Milan (Master in Neonatology and Upgrade Course in Mechanical Ventilation), academic course, since 2002 to present.
Adjunct Professor at the Pediatrics School of the University of Milan since academic course 2014/2015
100 scientific papers published on Pub-Med web site.Co-Author of : a chapter on the book “Genetics of epilepsy and genetic epilepsies”, edited by Fondazione Mariani in 2010; a chapter on mechanical ventilation and on N-CPAP on Neonatology Textbook 2017 edition; a chapter on lung volume optimization on Manual of Neonatal Respiratory Care (2017); a chapter entitled “Prenatal attachment in twin pregnancy” on the book “Multiple Pregnancy : new challenges “edited by Julio Elito Jr, 2019).Coauthorof the chapter “Sustained lung inflation” on the book “ Essentials of Neonatal Ventilation” , Elsevier Edition, 1st edition, 2019.
Dr. Cataldo is a physician anesthesiologist with CareMount Medical serving Westchester and Putnam Counties in NY. With extensive clinical experience in anesthetic delivery and critical care, he aims to improve patient care and safety through medical device design and implementation. Steven believes that successful innovation in medical care revolves around offering new techniques and procedures available to clinicians through device design. Rather than modifying current market devices to add new features or decrease failures, effective change within the field relies on the evolution of healthcare moving forward, using science and technology to create novel ways to support patients’ physiologic needs.
Through the design and implementation of the SuperNO2VA™ platform, Steven has pioneered a new modality of airway management and respiratory care through controlled nasal ventilation. This makes use of the body’s most natural route of ventilation and allows for improved care in patients receiving anesthetic medications without advanced airway management, paralleling the current trends in minimally invasive medical care and maximizing clinician workflow. To train this new clinical care delivery system and its associated novel market within sedation anesthesia, Steven enjoys being in the field, traveling and teaching clinicians in person within the operating room, lecture hall, and at international meetings.
Dr. Cataldo earned his M.D. and completed his residency training in Anesthesia at SUNY Downstate Medical Center in Brooklyn, NY. He is an active member of the American Society of Anesthesiologists, New York State Society of Anesthesiologists, Society for Airway Management, and Society for Head and Neck Anesthesia.
Prof Ross Freebairn is well known as an expert in the field of intensive care and has published many studies on important topics of lung protection strategies.
His lecture will explain how the use of PEEP is one of the most important parts of the ventilation treatment package and probably the least understood as well. Professor Freebairn will explain the reasons why PEEP should be considered and how it should be set based on the patients clinical status and lung condition.
Full-time Professor of Respiratory and Critical Care University of Bologna
Director of the fellowship progam
Chief of the Respiratory and Critical Care Sant’ Orsola Malpighi Hospital in Bologna, Italy
Former Associate professor at: Pavia, Catania and Bologna Universities
Specialist in Respiratory Medicine and Intensive Care Medicine.
Associate Editor of Breathe, Respiratory Care and European Respiratory Review
Previous Associate Editor of Intensive Care Medicine.
Previous member of the Editorial Board of Thorax
Reviewers of more than 10 international peer-reviewed journals, including the Lancet, American Journal of Respiratory and Critical Care Medicine
Chairman of the Intensive Care assembly at the European Respiratory Society (2007-2010).
Director of the ERS Post-Graduate Courses (2011-2015)
Previous member of the European Respiratory School.
Previous chair of the non-invasive ventilator support group inside the ERS
He was involved in the last 7 years as a member of the Assembly (Critical Care) Program Committee at the ATS.
Chairman of the International Program Committee of the American Thoracic Society for 2008-2009
Recepient of Gaza Award from the AARC in 2011
Honorary Membership of Hungarian Respiratory Society 2012
Honorary Egan at Lecture AARC 2012
Educational Award ERS 2017
He has published 261 papers on peer-reviewed journals
Latest H index= 61 (total number of citations = 14.826) n. 46 on the list of Top Italian Scientists Clinical Sciences
He was enrolled in several clinical trials.
Major fields of interest: mechanical ventilation, weaning, respiratory muscle and ethics.
In particular he has developed the use of non-invasive mechanical ventilation as a weaning technique
Hobbies: Movies, Reading, Travelling and cheese taster. Actual skier and former soccer player.
Lluís Blanch MD, PhD
Dr. Blanch's research interests include, but are not limited to, translational investigation of lung and brain injuries, mechanical ventilation, digital therapies and artificial intelligence applied to monitoring of respiratory and hemodynamic signals of critical patients. He has received numerous grants from public and non-profit organizations and has more than 235 Publications indexed in Pub Med with an H index of 44.
He has been a member of the Executive Committee of the European Society of Intensive Care Medicine, President of the Spanish Society of Intensive Medicine and Coronary Units, as well as President of the Catalan Critical Care Society and member of the World Federation of Societies of Intensive and Critical Care Medicine Council up to the 2019 congress. Dr. Blanch is a member of the editorial board of several journals and a reviewer for the most prestigious journals in the fields of respiratory and critical care.
Innovative, results-oriented, experienced, and knowledgeable Healthcare leader with 25 years of experience in healthcare. Superior managerial ability, exceptional interpersonal and communication skills (written and oratory), who quickly absorbs and processes large amounts of information, and is capable of mastering health system values and achieving organizational objectives and metrics individually or as a team member. A resourceful decision-maker who combines integrity, exemplary leadership, and proven operational skill with the ability to resolve complex business issues.
************************************************************************
Public Speaker ~ Having presented multiple presentations at National and International meetings in Denver, San Diego, Tampa, Philadelphia, Ottawa, Miami, Kansas, San Antonio, Las Vegas, Duke University, Atlanta, Orlando, Nova Scotia, Boston, Vancouver, Nova Scotia, Charlotte, Philadephia, and Savannah, Georgia
************************************************************************
Community leader ~ Having taken part in Community Health fairs, HIV/AIDS prevention programs, Colo-rectal cancer screening program. Youth leadership development, Mentoring, Planning and organizing successful Networking events for community professionals, Youth Group leader
1) surfactant catabolism and development surfactant protection;
2) clinical development of point of care ultrasound in NICU and PICU;
3) new ventilatory strategies (NAVA and NHFOV) for pediatric and neonatal forms of respiratory failure;
4) epidemiology of neonatal and pediatric ARDS;
5) development of clinical management of neonatal jaundice.
He published 186 papers in extenso. Most of them in journals in the first quartile of the
“pediatrics” or “critical care” list. He also authored 19 between monographies and chapters
in books; editor of one monography. He wrote the introduction of 3 monography and gave
more than 200 presentations to international meetings/congresses often upon invitation.
Notably he published in Lancet, Lancet Respiratory Medicine, Lancet Child Health,
AJRCCM, European Respiratory Journal, Pediatrics, JAMA Pediatrics, Intensive Care
Medicine, Critical Care, Journal of Clinical Pharmacology, PlosOne amongst the others.
Main research record may be found here
The following graph describe the overtime trend of citations and publications (Scopus, Jan
2020):
Daniele De Luca has been also awarded the Acta Paediatrica Young Investigator award
(2007), the Italian National Award for Neonatal Research (2010), the ESPR Young
Investigator Award (2010) and the Bengt Robertson Award for Surfactant Research in
2018.
He has been Deputy Chair of “Respiratory Section” of the European Society for Pediatric and
Neonatal Intensive Care (ESPNIC) since 2011 to 2016. In oct 2016 he has been elected as
ESPNIC Secretary. He also serves as the European Society for Pediatric Research (ESPR)
Scientific Content Manager and ESPR Officer for Accreditation European Society for Pediatric
Research since 2013. He has been Referee for several major international journals in the
general medicine, critical care and pediatric field. He also served as Referee for several
national and international grant programs (Italy, France, Canada, Germany, Netherland, South
Africa, EU).
Dr. Dellacà main activities are in the field of Biomedical technologies.
His research interests are in the area of respiratory physiology, in particular on respiratory mechanics, linear and non-linear modelling of respiratory system mechanical properties, development of new technologies for the analysis of respiration, mechanical ventilation and anaesthesia. He is responsible or collaborating to several research projects sponsored by public agencies, foundations and companies.
He is author of 22 papers published on international peer-reviewed journals, 8 book chapters and 7 patents.
Tom Cahill MS, RRT-NPS, FAARC
Tom has been a Respiratory Therapist for over 27 years, most of that time in a leadership role. During his career he has worked in pediatrics, burns, LTACH, Industry and transport. He is a published author and has presented locally, regionally, nationally, and internationally. His former roles include Clinical Director of Respiratory Care at Cincinnati Childrens Hospital Medical Center and Clinical Manager at Shriners Hospital for Children-Cincinnati. Tom is currently the System Director of Respiratory, Sleep, EEG, PFT and Pulmonary Rehab for St Elizabeth Healthcare in Northern KY and Southeast IN.
Brian Graham is currently Professor Emeritus at the University of Saskatchewan, Saskatoon, Canada in the Division of Respirology, Critical Care and Sleep Medicine and has been a member of the Division since 1976.
He spent most of his career doing research on pulmonary function testing. He chaired both of the joint American Thoracic Society and European Respiratory Society task forces to develop international standards for the measurement of diffusing capacity of the lung in 2017 and for the measurement of spirometry in 2019.
He received the 2020 American Thoracic Society Robert Crapo Lifetime Achievement Award, which recognizes seminal advances in the use of pulmonary function testing, diagnostics, standardization and application that has impacted diagnostic approaches and pulmonary function testing on a global scale.
He also received the 2021 Canadian Thoracic Society Distinguished Achievement Award in recognition of his exceptional service as an innovative leader and researcher in the field of pulmonary function standards and testing.
